{"id":"https://openalex.org/W2811156840","doi":"https://doi.org/10.18433/jpps29856","title":"Therapeutic Doses of Eltrombopag do not Inhibit Hepatic BCRP in Healthy Volunteers: Intravenous Ceftriaxone as a Model","display_name":"Therapeutic Doses of Eltrombopag do not Inhibit Hepatic BCRP in Healthy Volunteers: Intravenous Ceftriaxone as a Model","publication_year":2018,"publication_date":"2018-06-27","ids":{"openalex":"https://openalex.org/W2811156840","doi":"https://doi.org/10.18433/jpps29856","mag":"2811156840","pmid":"https://pubmed.ncbi.nlm.nih.gov/29949502"},"language":"en","primary_location":{"id":"doi:10.18433/jpps29856","doi":"https://doi.org/10.18433/jpps29856","is_oa":true,"landing_page_url":"https://doi.org/10.18433/jpps29856","pdf_url":"https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/download/29856/21429","source":{"id":"https://openalex.org/S166796225","display_name":"Journal of Pharmacy & Pharmaceutical Sciences","issn_l":"1482-1826","issn":["1482-1826"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313003","host_organization_name":"Canadian Society for Pharmaceutical Sciences","host_organization_lineage":["https://openalex.org/P4310313003"],"host_organization_lineage_names":["Canadian Society for Pharmaceutical Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy & Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/download/29856/21429","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111388511","display_name":"Daniel Valente Neves","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Daniel Valente Neves","raw_affiliation_strings":["Departamento de An\u00e1lises Cl\u00ednicas, Toxicol\u00f3gicas e Bromatol\u00f3gicas, Faculdade de Ci\u00eancias Farmac\u00eauticas de Ribeir\u00e3o Preto, Universidade de S\u00e3o Paulo, Ribeir\u00e3o Preto, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de An\u00e1lises Cl\u00ednicas, Toxicol\u00f3gicas e Bromatol\u00f3gicas, Faculdade de Ci\u00eancias Farmac\u00eauticas de Ribeir\u00e3o Preto, Universidade de S\u00e3o Paulo, Ribeir\u00e3o Preto, SP, Brazil","institution_ids":["https://openalex.org/I17974374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044416846","display_name":"Carolina Pinto Vieira","orcid":"https://orcid.org/0000-0001-9134-0315","observed_orcids":["https://orcid.org/0000-0001-9134-0315"]},"institutions":[{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Carolina Pinto Vieira","raw_affiliation_strings":["Departamento de An\u00e1lises Cl\u00ednicas, Toxicol\u00f3gicas e Bromatol\u00f3gicas, Faculdade de Ci\u00eancias Farmac\u00eauticas de Ribeir\u00e3o Preto, Universidade de S\u00e3o Paulo, Ribeir\u00e3o Preto, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de An\u00e1lises Cl\u00ednicas, Toxicol\u00f3gicas e Bromatol\u00f3gicas, Faculdade de Ci\u00eancias Farmac\u00eauticas de Ribeir\u00e3o Preto, Universidade de S\u00e3o Paulo, Ribeir\u00e3o Preto, SP, Brazil","institution_ids":["https://openalex.org/I17974374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101949263","display_name":"Adriana Rocha","orcid":"https://orcid.org/0000-0003-4824-6571","observed_orcids":["https://orcid.org/0000-0003-4824-6571"]},"institutions":[{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Adriana Rocha","raw_affiliation_strings":["Departamento de An\u00e1lises Cl\u00ednicas, Toxicol\u00f3gicas e Bromatol\u00f3gicas, Faculdade de Ci\u00eancias Farmac\u00eauticas de Ribeir\u00e3o Preto, Universidade de S\u00e3o Paulo, Ribeir\u00e3o Preto, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de An\u00e1lises Cl\u00ednicas, Toxicol\u00f3gicas e Bromatol\u00f3gicas, Faculdade de Ci\u00eancias Farmac\u00eauticas de Ribeir\u00e3o Preto, Universidade de S\u00e3o Paulo, Ribeir\u00e3o Preto, SP, Brazil","institution_ids":["https://openalex.org/I17974374"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062445533","display_name":"Vera L\u00facia Lanchote","orcid":"https://orcid.org/0000-0002-0074-4953","observed_orcids":["https://orcid.org/0000-0002-0074-4953"]},"institutions":[{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Vera Lucia Lanchote","raw_affiliation_strings":["Departamento de An\u00e1lises Cl\u00ednicas, Toxicol\u00f3gicas e Bromatol\u00f3gicas, Faculdade de Ci\u00eancias Farmac\u00eauticas de Ribeir\u00e3o Preto, Universidade de S\u00e3o Paulo, Ribeir\u00e3o Preto, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de An\u00e1lises Cl\u00ednicas, Toxicol\u00f3gicas e Bromatol\u00f3gicas, Faculdade de Ci\u00eancias Farmac\u00eauticas de Ribeir\u00e3o Preto, Universidade de S\u00e3o Paulo, Ribeir\u00e3o Preto, SP, Brazil","institution_ids":["https://openalex.org/I17974374"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I17974374"],"apc_list":{"value":2200,"currency":"USD","value_usd":2200},"apc_paid":{"value":2200,"currency":"USD","value_usd":2200},"fwci":0.5282,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.67625494,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"21","issue":"1","first_page":"236","last_page":"246"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.027899999171495438,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eltrombopag","display_name":"eltrombopag","score":0.996999979019165},{"id":"https://openalex.org/keywords/ceftriaxone","display_name":"ceftriaxone","score":0.9739999771118164},{"id":"https://openalex.org/keywords/bcrp-inhibition","display_name":"BCRP inhibition","score":0.7929999828338623},{"id":"https://openalex.org/keywords/mrp2","display_name":"MRP2","score":0.6980000138282776},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7829999923706055},{"id":"https://openalex.org/keywords/hepatic-drug-transporters","display_name":"hepatic drug transporters","score":0.6100000143051147},{"id":"https://openalex.org/keywords/unbound-drug-concentration","display_name":"unbound drug concentration","score":0.6759999990463257},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.34200000762939453},{"id":"https://openalex.org/keywords/thrombopoietin-receptor-agonists","display_name":"thrombopoietin receptor agonists","score":0.7950000166893005},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.4690000116825104},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.6639999747276306},{"id":"https://openalex.org/keywords/lc-ms-ms-method-validation","display_name":"LC-MS/MS method validation","score":0.7239999771118164}],"concepts":[{"id":"https://openalex.org/C2776520383","wikidata":"https://www.wikidata.org/wiki/Q421713","display_name":"Ceftriaxone","level":3,"score":0.9330013990402222},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7927142977714539},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.699604868888855},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6746994853019714},{"id":"https://openalex.org/C2780588981","wikidata":"https://www.wikidata.org/wiki/Q411588","display_name":"Eltrombopag","level":4,"score":0.5558028221130371},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.45970281958580017},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3118356466293335},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2823668122291565},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.21220016479492188},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.11249515414237976},{"id":"https://openalex.org/C2993327898","wikidata":"https://www.wikidata.org/wiki/Q638729","display_name":"Immune thrombocytopenia","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000070997","descriptor_name":"ATP Binding Cassette Transporter, Subfamily G, Member 2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000070997","descriptor_name":"ATP Binding Cassette Transporter, Subfamily G, Member 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000070997","descriptor_name":"ATP Binding Cassette Transporter, Subfamily G, Member 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000089762","descriptor_name":"Multidrug Resistance-Associated Protein 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002443","descriptor_name":"Ceftriaxone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002443","descriptor_name":"Ceftriaxone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002443","descriptor_name":"Ceftriaxone","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006834","descriptor_name":"Hydrazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006834","descriptor_name":"Hydrazines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006834","descriptor_name":"Hydrazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D007422","descriptor_name":"Intestines","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D022781","descriptor_name":"Hepatocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D022781","descriptor_name":"Hepatocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061605","descriptor_name":"Administration, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.18433/jpps29856","doi":"https://doi.org/10.18433/jpps29856","is_oa":true,"landing_page_url":"https://doi.org/10.18433/jpps29856","pdf_url":"https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/download/29856/21429","source":{"id":"https://openalex.org/S166796225","display_name":"Journal of Pharmacy & Pharmaceutical Sciences","issn_l":"1482-1826","issn":["1482-1826"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313003","host_organization_name":"Canadian Society for Pharmaceutical Sciences","host_organization_lineage":["https://openalex.org/P4310313003"],"host_organization_lineage_names":["Canadian Society for Pharmaceutical Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy & Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:29949502","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29949502","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:9be939847e9e4d3ba76098651b0b6630","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/9be939847e9e4d3ba76098651b0b6630","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Pharmacy & Pharmaceutical Sciences, Vol 21, Iss 1 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.18433/jpps29856","doi":"https://doi.org/10.18433/jpps29856","is_oa":true,"landing_page_url":"https://doi.org/10.18433/jpps29856","pdf_url":"https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/download/29856/21429","source":{"id":"https://openalex.org/S166796225","display_name":"Journal of Pharmacy & Pharmaceutical Sciences","issn_l":"1482-1826","issn":["1482-1826"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313003","host_organization_name":"Canadian Society for Pharmaceutical Sciences","host_organization_lineage":["https://openalex.org/P4310313003"],"host_organization_lineage_names":["Canadian Society for Pharmaceutical Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy & Pharmaceutical Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3572101131","display_name":null,"funder_award_id":"2014/","funder_id":"https://openalex.org/F4320320997","funder_display_name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo"}],"funders":[{"id":"https://openalex.org/F4320320997","display_name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","ror":"https://ror.org/02ddkpn78"},{"id":"https://openalex.org/F4320322025","display_name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","ror":"https://ror.org/03swz6y49"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2811156840.pdf","grobid_xml":"https://content.openalex.org/works/W2811156840.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W49772452","https://openalex.org/W170297004","https://openalex.org/W176608813","https://openalex.org/W1515676175","https://openalex.org/W1549886821","https://openalex.org/W1968124824","https://openalex.org/W1993862445","https://openalex.org/W1995458482","https://openalex.org/W2013946336","https://openalex.org/W2031083224","https://openalex.org/W2048047193","https://openalex.org/W2053184918","https://openalex.org/W2064658424","https://openalex.org/W2078446310","https://openalex.org/W2079197876","https://openalex.org/W2093431494","https://openalex.org/W2102765259","https://openalex.org/W2103068347","https://openalex.org/W2108950280","https://openalex.org/W2111715648","https://openalex.org/W2118784523","https://openalex.org/W2122573612","https://openalex.org/W2141941946","https://openalex.org/W2157847692","https://openalex.org/W2166082449","https://openalex.org/W2169044544","https://openalex.org/W2171722987","https://openalex.org/W2234611863","https://openalex.org/W2642070909","https://openalex.org/W2754298368"],"related_works":["https://openalex.org/W7096657022","https://openalex.org/W2153948507","https://openalex.org/W7095243395","https://openalex.org/W1973127418","https://openalex.org/W3142950998","https://openalex.org/W3082463310","https://openalex.org/W2092534997","https://openalex.org/W2461302550","https://openalex.org/W2308755764","https://openalex.org/W1966869910"],"abstract_inverted_index":{"PURPOSE:":[0],"Ceftriaxone":[1,180],"elimination":[2],"occurs":[3],"through":[4],"breast":[5],"cancer":[6],"resistance":[7],"transporter":[8],"(BCRP)":[9],"and":[10,93,114,127,138,147,161,175,178,200,218,235,242,282],"multidrug":[11],"resistance-associated":[12],"protein":[13],"2":[14],"(MRP-2)":[15],"which":[16],"are":[17,158],"expressed":[18],"on":[19,69,301,303],"the":[20,32,58,62,70,171,265,304],"canalicular":[21],"membrane":[22],"of":[23,34,47,54,64,67,73,85,165,173,195,213,220,233,237,244,257,267],"hepatocytes.":[24],"Eltrombopag,":[25],"a":[26,188,192,268],"thrombopoetin":[27],"receptor":[28],"agonist":[29],"used":[30],"in":[31,40,41,141,170,182,276],"treatment":[33],"immune":[35],"thrombocytopenic":[36],"purpura,":[37],"is":[38,287],"reported":[39],"vitro":[42],"studies":[43],"as":[44],"an":[45,52],"inhibitor":[46,53],"intestinal":[48],"BCRP":[49,275],"but":[50],"not":[51,263],"hepatic":[55,274],"BCRP.":[56],"Thus,":[57],"present":[59],"study":[60,172],"evaluates":[61],"effect":[63],"therapeutic":[65],"doses":[66,84],"eltrombopag":[68,86,234],"clinical":[71,269],"pharmacokinetics":[72,181],"intravenous":[74,98,280],"ceftriaxone.":[75],"METHODS:":[76],"Healthy":[77],"adult":[78],"(n=12)":[79],"were":[80,105,117,185],"treated":[81],"with":[82,149,163,191],"oral":[83,283],"(0,":[87],"25":[88,231],"or":[89],"50":[90,122,255],"mg)":[91],"28":[92],"4":[94],"h":[95,110],"prior":[96],"to":[97,108,135,153,289],"ceftriaxone":[99,112,140,229,253,281],"administration":[100,113],"(1g).":[101],"Serial":[102],"blood":[103],"samples":[104,116],"collected":[106],"up":[107],"48":[109],"after":[111],"plasma":[115,142],"analysed":[118],"by":[119,299],"LC-MS/MS":[120,144],"using":[121,143,187],"\u03bcL":[123,129],"aliquots":[124],"(total":[125],"concentration)":[126],"100":[128],"(unbound":[130],"concentration).":[131],"RESULTS:":[132],"A":[133],"method":[134],"analyze":[136],"total":[137],"unbound":[139],"was":[145],"developed":[146],"validated":[148],"linearity":[150],"from":[151],"1":[152],"200":[154],"\u03bcg/mL.":[155],"Both":[156],"methods":[157],"sensitive,":[159],"precise":[160],"accurate":[162],"coefficients":[164],"variation":[166],"less":[167],"than":[168],"15%":[169],"inter-":[174],"intra-assay":[176],"precision":[177],"accuracy.":[179],"healthy":[183],"adults":[184],"described":[186],"bicompartmental":[189],"model,":[190],"mean":[193],"clearance":[194,212,236],"0.96":[196,238],"L/h":[197,215,239],"(CI95%":[198,204,216,223,240,247],"0.71-1.20)":[199],"AUC0-\u221eof":[201],"1106":[202],"mg.h/mL":[203,222,246],"811-1400)":[205],"for":[206,225,249],"volunteers":[207,226,250],"that":[208,227,251],"received":[209,228,252],"only":[210],"ceftriaxone;":[211],"0.95":[214],"0.77-1.13)":[217],"AUC0-\u221e":[219,243],"1083":[221],"876-1290)":[224],"plus":[230,254],"mg":[232,256],"0.74-1.19)":[241],"1072":[245],"872-1273)":[248],"eltrombopag.":[258,284],"CONCLUSIONS:":[259],"The":[260],"results":[261],"do":[262],"support":[264],"existence":[266],"pharmacokinetic":[270],"drug":[271],"interaction":[272],"involving":[273],"human":[277],"subjects":[278],"receiving":[279],"This":[285],"article":[286],"open":[288],"POST-PUBLICATION":[290],"REVIEW.":[291],"Registered":[292],"readers":[293],"(see":[294],"\"For":[295],"Readers\")":[296],"may":[297],"comment":[298],"clicking":[300],"ABSTRACT":[302],"issue's":[305],"contents":[306],"page.":[307]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-07-10T00:00:00"}